The GAPSID Study - How GLP-1 Analogues Prevent Steroid-Induced Diabetes — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

The GAPSID Study - How GLP-1 Analogues Prevent Steroid-Induced Diabetes — Stella

Recruiting

Back to Steroid-Induced Diabetes trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

United Kingdom

Imperial College Healthcare NHS Trust, London

Key details

Sponsor

Imperial College London

Enrollment target

~60 participants

Started

May 2024

Primary completion

June 2027

Age range

18 Years and older

Last updated October 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov